Srinivas Gosla Reddy: Alveolar Bone Grafting in Cleft Patients: Timing, Techniques, and Outcomes.

This event is eligible for EACCME® accreditation.

1. Join the Pro Learning Circle to access CME benefits and qualify for credit.

2. After attending the full live event and completing the required activities, claim your CME credits here.

Need more details? Visit our Accreditation Information page.

Join us for an insightful talk on the critical aspects of alveolar bone grafting (ABG) for individuals with cleft lip and palate. The discussion will focus on the importance of timing the procedure, typically between the ages of 8 and 12, to achieve optimal outcomes for dental and facial development. Various ABG techniques, such as iliac crest bone grafting and synthetic graft materials, will be explored, with an emphasis on selecting the best approach based on the patient's condition. The talk will also cover the long-term outcomes, including the success of grafts in dental arch development, speech improvement, and preventing further deformities, while addressing potential complications and the need for ongoing care.

LEARNING OBJECTIVES

By the end of this session, participants will be able to:

• Explain the significance of proper timing for alveolar bone grafting (ABG) in patients with cleft lip and palate, particularly during the mixed dentition phase (ages 8–12).

• Compare and contrast common ABG techniques, including iliac crest bone grafting and synthetic graft materials, and identify appropriate indications for each.

• Evaluate long-term outcomes of ABG with respect to dental arch development, speech enhancement, and craniofacial stability.

• Recognize potential complications associated with ABG procedures and formulate strategies for management and ongoing care.

• Apply patient-specific factors to optimize surgical planning and improve functional and aesthetic outcomes in cleft care.

  
  

TARGET AUDIENCE

• Oral and Maxillofacial Surgeons

• Plastic and Reconstructive Surgeons

• Pediatric Dentists and Orthodontists

• Otolaryngologists (ENT specialists)

• Craniofacial Surgeons

• Speech and Language Pathologists involved in cleft care

• Surgical Residents and Fellows specializing in craniofacial anomalies

• Allied health professionals in cleft and craniofacial teams

ABOUT THE SPEAKER Prof Dr Dr Srinivas Gosla Reddy BDS, MBBS, MDS, FRCS (Edin.), FRCS (Glasg), FDSRCS (Edin.), FDSRCS (Eng.), FDSRCPS (Glasg), PhD (the Netherlands) is a renowned Craniofacial Surgeon specializing in the treatment of facial defects and cosmetic facial surgery. He holds a Master of Dental Surgery (MDS) in Oral and Maxillofacial Surgery and has trained extensively in craniofacial centers across Europe. Prof. Gosla is the founder of the GSR Institute of Craniofacial and Facial Plastic Surgery in Hyderabad, India, where he treats over 1,500 patients annually. He is also a Professor at several prestigious institutions, including the University of Timisoara and AIIMS Rishikesh, and runs a Fellowship program in Cleft and Craniofacial Surgery. Additionally, he has established a school for disadvantaged children with cleft and craniofacial defects and actively partners with international organizations to fund treatments for these patients.

ONLINE LIVE EVENT (Free of Charge)

LANGUAGE: The event language is english. 

DECLARATION: In accordance with criterion 13 of document UEMS 2023.07.rev “EACCME® Criteria for the Accreditation of Live Educational Events (LEEs)” and the Standard v. Commercial or Promotional Conflict of Interest, published by the American Dental Association Continuing Education Recognition Program (ADA CERP), all surgeON presenters sign a Conflict of Interest form to document all perceived or actual conflicts of interest for the last 3 years, whether due to a financial or other relationship. This document can be viewed at the beginning of the event or on request by emailing info@surgeon-events.org No fee, honorarium or arrangement for re-imbursement of expenses in relation to the this event has been provided to the speaker.